Abstract Objective To study the value of heparin-binding protein (HBP) in the diagnosis of severe infection in children. Methods This study was a prospective observational study. The medical data of children who were admitted to the pediatric intensive care unit due to infection from January 2019 to January 2020 were collected. According to the diagnostic criteria for severe sepsis and sepsis, the children were divided into a severe sepsis group with 49 children, a sepsis group with 82 children, and a non-severe infection group with 33 children. The three groups were compared in terms of related biomarkers such as plasma HBP, serum C-reactive protein, serum procalcitonin, and platelet count. The receiver operating characteristic (ROC) curve was plotted to investigate the value of plasma HBP level in the diagnosis of severe infection (including severe sepsis and sepsis). Results The severe sepsis and sepsis groups had a significantly higher plasma HBP level on admission than the non-severe infection group (P<0.05). Compared with the sepsis and non-severe groups, the severe sepsis group had significantly higher serum levels of C-reactive protein and procalcitonin and a significantly lower platelet count (P<0.05). Plasma HBP level had an area under the ROC curve of 0.590 in determining severe infection, with a sensitivity of 38.0% and a specificity of 82.4% (P<0.05). Conclusions There is an increase in plasma HBP level in children with severe infection, and plasma HBP level has a lower sensitivity but a higher specificity in the diagnosis of severe infection and can thus be used as one of the markers for the judgment of severe infection in children.
DENG Jun-Chao,ZHAO Fang-Li,QIAO Li-Na. Value of heparin-binding protein in the diagnosis of severe infection in children: a prospective study[J]. CJCP, 2022, 24(1): 85-89.
DENG Jun-Chao,ZHAO Fang-Li,QIAO Li-Na. Value of heparin-binding protein in the diagnosis of severe infection in children: a prospective study[J]. CJCP, 2022, 24(1): 85-89.
Linder A, Arnold R, Boyd JH, et al. Heparin-binding protein measurement improves the prediction of severe infection with organ dysfunction in the emergency department[J]. Crit Care Med, 2015, 43(11): 2378-2386. PMID: 26468696. PMCID: PMC4603368. DOI: 10.1097/CCM.0000000000001265.
Fisher J, Linder A. Heparin-binding protein: a key player in the pathophysiology of organ dysfunction in sepsis[J]. J Intern Med, 2017, 281(6): 562-574. PMID: 28370601. DOI: 10.1111/joim.12604.
Linder A, Christensson B, Herwald H, et al. Heparin-binding protein: an early marker of circulatory failure in sepsis[J]. Clin Infect Dis, 2009, 49(7): 1044-1050. PMID: 19725785. DOI: 10.1086/605563.
Kahn F, Tverring J, Mellhammar L, et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the emergency department[J]. Shock, 2019, 52(6): e135-e145. PMID: 30807529. DOI: 10.1097/SHK.0000000000001332.
Wu YL, Yo CH, Hsu WT, et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis[J]. Crit Care Med, 2021, 49(1): e80-e90. PMID: 33196528. DOI: 10.1097/CCM.0000000000004738.
Liu XW, Ma T, Liu W, et al. Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis[J]. J Crit Care, 2018, 45: 14-19. PMID: 29413717. DOI: 10.1016/j.jcrc.2018.01.010.
Rey C, Los Arcos M, Concha A, et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children[J]. Intensive Care Med, 2007, 33(3): 477-484. PMID: 17260130. DOI: 10.1007/s00134-006-0509-7.
Gaertner F, Ahmad Z, Rosenberger G, et al. Migrating platelets are mechano-scavengers that collect and bundle bacteria[J]. Cell, 2017, 171(6): 1368-1382.e23. PMID: 29195076. DOI: 10.1016/j.cell.2017.11.001.
Alfano DN, Bubeck Wardenburg J. Another score for the pore: S. aureus leukocidins take a shot on the endothelium[J]. Cell Host Microbe, 2019, 25(3): 351-353. PMID: 30870619. DOI: 10.1016/j.chom.2019.02.011.
WANG Hui-Min, LIU Chuan-He, LIU Chang-Shan, WANG Ying, HAN Zhi-Ying, SUN Xin, CHEN Xing, AN Shu-Hua, DUOLIKUN Muzhapaer, LU Ai-Ping, WANG Min, CHENG Yan, YIN Xiao-Mei, LIU Han-Min, WANG Hong, HUA Shan, DONG Li, HUANG Ying, JIANG Yi, XIONG Jian-Xin, DING Sheng-Gang, ZHAO Shun-Ying, WANG Jin-Rong, HUANG Gui-Min, MU Jing-Hui, CHEN Yu-Zhi. Efficacy of Huaiqihuang granules as adjuvant therapy for bronchial asthma in children: a real-world study[J]. CJCP, 2021, 23(9): 877-881.